{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T20:19:31Z","timestamp":1772223571453,"version":"3.50.1"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,9,28]],"date-time":"2018-09-28T00:00:00Z","timestamp":1538092800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"research grant by Leo Pharma GmbH, Neu-Isenburg, Germany."}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Med Res"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1186\/s40001-018-0343-8","type":"journal-article","created":{"date-parts":[[2018,9,28]],"date-time":"2018-09-28T07:34:25Z","timestamp":1538120065000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Ingenol mebutate induces a tumor cell-directed inflammatory response and antimicrobial peptides thereby promoting rapid tumor destruction and wound healing"],"prefix":"10.1186","volume":"23","author":[{"given":"Stephan Alexander","family":"Braun","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julia","family":"Baran","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Holger","family":"Schrumpf","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bettina Alexandra","family":"Buhren","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Edwin","family":"B\u00f6lke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bernhard","family":"Homey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter Arne","family":"Gerber","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,9,28]]},"reference":[{"key":"343_CR1","doi-asserted-by":"publisher","first-page":"1010","DOI":"10.1056\/NEJMoa1111170","volume":"366","author":"M Lebwohl","year":"2012","unstructured":"Lebwohl M, Swanson N, Anderson LL, Melgaard A, Xu Z, Berman B. Ingenol mebutate gel for actinic keratosis. N Engl J Med. 2012;366:1010\u20139.","journal-title":"N Engl J Med"},{"key":"343_CR2","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1016\/j.jaad.2010.12.038","volume":"66","author":"RH Rosen","year":"2012","unstructured":"Rosen RH, Gupta AK, Tyring SK. Dual mechanism of action of ingenol mebutate gel for topical treatment of actinic keratoses: rapid lesion necrosis followed by lesion-specific immune response. J Am Acad Dermatol. 2012;66:486\u201393.","journal-title":"J Am Acad Dermatol"},{"key":"343_CR3","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1158\/1535-7163.1651.3.12","volume":"3","author":"SK Gillespie","year":"2004","unstructured":"Gillespie SK, Zhang XD, Hersey P. Ingenol 3-angelate induces dual modes of cell death and differentially regulates tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis in melanoma cells. Mol Cancer Ther. 2004;3:1651\u20138.","journal-title":"Mol Cancer Ther"},{"key":"343_CR4","doi-asserted-by":"publisher","first-page":"2833","DOI":"10.1158\/0008-5472.CAN-03-2837","volume":"64","author":"SM Ogbourne","year":"2004","unstructured":"Ogbourne SM, Suhrbier A, Jones B, Cozzi SJ, Boyle GM, Morris M, McAlpine D, Johns J, Scott TM, Sutherland KP, et al. Antitumor activity of 3-ingenyl angelate: plasma membrane and mitochondrial disruption and necrotic cell death. Cancer Res. 2004;64:2833\u20139.","journal-title":"Cancer Res"},{"key":"343_CR5","first-page":"1181","volume":"11","author":"M Stahlhut","year":"2012","unstructured":"Stahlhut M, Bertelsen M, Hoyer-Hansen M, Svendsen N, Eriksson AH, Lord JM, Scheel-Toellner D, Young SP, Zibert JR. Ingenol mebutate: induced cell death patterns in normal and cancer epithelial cells. J Drugs Dermatol. 2012;11:1181\u201392.","journal-title":"J Drugs Dermatol"},{"key":"343_CR6","doi-asserted-by":"publisher","first-page":"8123","DOI":"10.4049\/jimmunol.177.11.8123","volume":"177","author":"JM Challacombe","year":"2006","unstructured":"Challacombe JM, Suhrbier A, Parsons PG, Jones B, Hampson P, Kavanagh D, Rainger GE, Morris M, Lord JM, Le TT, et al. Neutrophils are a key component of the antitumor efficacy of topical chemotherapy with ingenol-3-angelate. J Immunol. 2006;177:8123\u201332.","journal-title":"J Immunol"},{"key":"343_CR7","doi-asserted-by":"publisher","first-page":"e0160096","DOI":"10.1371\/journal.pone.0160096","volume":"11","author":"S Emmert","year":"2016","unstructured":"Emmert S, Haenssle HA, Zibert JR, Schon M, Hald A, Hansen MH, Litman T, Schon MP. Tumor-preferential induction of immune responses and epidermal cell death in actinic keratoses by ingenol mebutate. PLoS ONE. 2016;11:e0160096.","journal-title":"PLoS ONE"},{"key":"343_CR8","doi-asserted-by":"publisher","first-page":"1362","DOI":"10.1182\/blood-2004-10-4117","volume":"106","author":"P Hampson","year":"2005","unstructured":"Hampson P, Chahal H, Khanim F, Hayden R, Mulder A, Assi LK, Bunce CM, Lord JM. PEP005, a selective small-molecule activator of protein kinase C, has potent antileukemic activity mediated via the delta isoform of PKC. Blood. 2005;106:1362\u20138.","journal-title":"Blood"},{"key":"343_CR9","doi-asserted-by":"publisher","first-page":"1241","DOI":"10.1007\/s00262-008-0458-9","volume":"57","author":"P Hampson","year":"2008","unstructured":"Hampson P, Kavanagh D, Smith E, Wang K, Lord JM, Ed Rainger G. The anti-tumor agent, ingenol-3-angelate (PEP005), promotes the recruitment of cytotoxic neutrophils by activation of vascular endothelial cells in a PKC-delta dependent manner. Cancer Immunol Immunother. 2008;57:1241\u201351.","journal-title":"Cancer Immunol Immunother"},{"key":"343_CR10","doi-asserted-by":"publisher","first-page":"3243","DOI":"10.1158\/0008-5472.CAN-03-3403","volume":"64","author":"N Kedei","year":"2004","unstructured":"Kedei N, Lundberg DJ, Toth A, Welburn P, Garfield SH, Blumberg PM. Characterization of the interaction of ingenol 3-angelate with protein kinase C. Cancer Res. 2004;64:3243\u201355.","journal-title":"Cancer Res"},{"key":"343_CR11","doi-asserted-by":"publisher","first-page":"4509","DOI":"10.1158\/0008-5472.CAN-09-4303","volume":"70","author":"L Li","year":"2010","unstructured":"Li L, Shukla S, Lee A, Garfield SH, Maloney DJ, Ambudkar SV, Yuspa SH. The skin cancer chemotherapeutic agent ingenol-3-angelate (PEP005) is a substrate for the epidermal multidrug transporter (ABCB1) and targets tumor vasculature. Cancer Res. 2010;70:4509\u201319.","journal-title":"Cancer Res"},{"key":"343_CR12","first-page":"616","volume":"14","author":"SA Braun","year":"2016","unstructured":"Braun SA, Gerber PA. Successful treatment of perianal condylomata acuminata with ingenol mebutate gel. J Dtsch Dermatol Ges. 2016;14:616\u20137.","journal-title":"J Dtsch Dermatol Ges"},{"key":"343_CR13","doi-asserted-by":"publisher","first-page":"e9","DOI":"10.1016\/j.jaad.2017.01.034","volume":"77","author":"SA Braun","year":"2017","unstructured":"Braun SA, Gerber PA. Ingenol mebutate for the management of genital warts in sensitive anatomic locations. J Am Acad Dermatol. 2017;77:e9\u201310.","journal-title":"J Am Acad Dermatol"},{"key":"343_CR14","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1007\/s00105-015-3593-1","volume":"66","author":"SA Braun","year":"2015","unstructured":"Braun SA, Jansen TM, Homey B, Gerber PA. Successful therapy of condylomata acuminata with ingenol mebutate. Hautarzt. 2015;66:223\u20135.","journal-title":"Hautarzt"},{"key":"343_CR15","doi-asserted-by":"publisher","first-page":"1041","DOI":"10.1111\/jdv.13097","volume":"30","author":"RE Schopf","year":"2015","unstructured":"Schopf RE. Ingenol mebutate gel is effective against anogenital warts\u2014a case series in 17 patients. J Eur Acad Dermatol Venereol. 2015;30:1041\u20133.","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"343_CR16","doi-asserted-by":"publisher","first-page":"e63949","DOI":"10.1371\/journal.pone.0063949","volume":"8","author":"PA Gerber","year":"2013","unstructured":"Gerber PA, Hevezi P, Buhren BA, Martinez C, Schrumpf H, Gasis M, Grether-Beck S, Krutmann J, Homey B, Zlotnik A. Systematic identification and characterization of novel human skin-associated genes encoding membrane and secreted proteins. PLoS ONE. 2013;8:e63949.","journal-title":"PLoS ONE"},{"key":"343_CR17","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1186\/1476-4598-10-30","volume":"10","author":"S Twarock","year":"2011","unstructured":"Twarock S, Freudenberger T, Poscher E, Dai G, Jannasch K, Dullin C, Alves F, Prenzel K, Knoefel WT, Stoecklein NH, et al. Inhibition of oesophageal squamous cell carcinoma progression by in vivo targeting of hyaluronan synthesis. Mol Cancer. 2011;10:30.","journal-title":"Mol Cancer"},{"key":"343_CR18","doi-asserted-by":"publisher","first-page":"3465","DOI":"10.4049\/jimmunol.164.7.3465","volume":"164","author":"B Homey","year":"2000","unstructured":"Homey B, Wang W, Soto H, Buchanan ME, Wiesenborn A, Catron D, Muller A, McClanahan TK, Dieu-Nosjean MC, Orozco R, et al. Cutting edge: the orphan chemokine receptor G protein-coupled receptor-2 (GPR-2, CCR10) binds the skin-associated chemokine CCL27 (CTACK\/ALP\/ILC). J Immunol. 2000;164:3465\u201370.","journal-title":"J Immunol"},{"key":"343_CR19","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1186\/gb-2006-7-12-243","volume":"7","author":"A Zlotnik","year":"2006","unstructured":"Zlotnik A, Yoshie O, Nomiyama H. The chemokine and chemokine receptor superfamilies and their molecular evolution. Genome Biol. 2006;7:243.","journal-title":"Genome Biol"},{"key":"343_CR20","doi-asserted-by":"publisher","first-page":"3652","DOI":"10.1073\/pnas.91.9.3652","volume":"91","author":"MW Carr","year":"1994","unstructured":"Carr MW, Roth SJ, Luther E, Rose SS, Springer TA. Monocyte chemoattractant protein 1 acts as a T-lymphocyte chemoattractant. Proc Natl Acad Sci USA. 1994;91:3652\u20136.","journal-title":"Proc Natl Acad Sci USA"},{"key":"343_CR21","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1158\/1538-7445.AM2011-275","volume":"1","author":"W Yan","year":"2011","unstructured":"Yan W, Wistuba II, Emmert-Buck MR, Erickson HS. Squamous cell carcinoma\u2014similarities and differences among anatomical sites. Am J Cancer Res. 2011;1:275\u2013300.","journal-title":"Am J Cancer Res"},{"key":"343_CR22","doi-asserted-by":"publisher","first-page":"545","DOI":"10.3390\/ph7050545","volume":"7","author":"G Wang","year":"2014","unstructured":"Wang G. Human antimicrobial peptides and proteins. Pharmaceuticals (Basel). 2014;7:545\u201394.","journal-title":"Pharmaceuticals (Basel)"},{"key":"343_CR23","doi-asserted-by":"publisher","first-page":"5707","DOI":"10.1074\/jbc.M008557200","volume":"276","author":"J Harder","year":"2001","unstructured":"Harder J, Bartels J, Christophers E, Schroder JM. Isolation and characterization of human beta-defensin-3, a novel human inducible peptide antibiotic. J Biol Chem. 2001;276:5707\u201313.","journal-title":"J Biol Chem"},{"key":"343_CR24","doi-asserted-by":"publisher","first-page":"46779","DOI":"10.1074\/jbc.M207587200","volume":"277","author":"J Harder","year":"2002","unstructured":"Harder J, Schroder JM. RNase 7, a novel innate immune defense antimicrobial protein of healthy human skin. J Biol Chem. 2002;277:46779\u201384.","journal-title":"J Biol Chem"},{"key":"343_CR25","doi-asserted-by":"publisher","first-page":"594","DOI":"10.1038\/sj.jid.5700599","volume":"127","author":"F Niyonsaba","year":"2007","unstructured":"Niyonsaba F, Ushio H, Nakano N, Ng W, Sayama K, Hashimoto K, Nagaoka I, Okumura K, Ogawa H. Antimicrobial peptides human beta-defensins stimulate epidermal keratinocyte migration, proliferation and production of proinflammatory cytokines and chemokines. J Invest Dermatol. 2007;127:594\u2013604.","journal-title":"J Invest Dermatol"},{"key":"343_CR26","doi-asserted-by":"publisher","first-page":"1197","DOI":"10.1111\/j.1365-2133.2009.09090.x","volume":"160","author":"A Kreuter","year":"2009","unstructured":"Kreuter A, Skrygan M, Gambichler T, Brockmeyer NH, Stucker M, Herzler C, Potthoff A, Altmeyer P, Pfister H, Wieland U. Human papillomavirus-associated induction of human beta-defensins in anal intraepithelial neoplasia. Br J Dermatol. 2009;160:1197\u2013205.","journal-title":"Br J Dermatol"},{"key":"343_CR27","doi-asserted-by":"publisher","first-page":"2132","DOI":"10.1158\/1535-7163.MCT-15-0023-T","volume":"14","author":"SN Freiberger","year":"2015","unstructured":"Freiberger SN, Cheng PF, Iotzova-Weiss G, Neu J, Liu Q, Dziunycz P, Zibert JR, Dummer R, Skak K, Levesque MP, Hofbauer GF. Ingenol mebutate signals via PKC\/MEK\/ERK in keratinocytes and induces interleukin decoy receptors IL1R2 and IL13RA2. Mol Cancer Ther. 2015;14:2132\u201342.","journal-title":"Mol Cancer Ther"},{"key":"343_CR28","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1002\/jcp.1041560308","volume":"156","author":"Y Ando","year":"1993","unstructured":"Ando Y, Lazarus GS, Jensen PJ. Activation of protein kinase C inhibits human keratinocyte migration. J Cell Physiol. 1993;156:487\u201396.","journal-title":"J Cell Physiol"},{"key":"343_CR29","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1006\/cyto.1998.0496","volume":"11","author":"E Kontny","year":"1999","unstructured":"Kontny E, Ziolkowska M, Ryzewska A, Maslinski W. Protein kinase c-dependent pathway is critical for the production of pro-inflammatory cytokines (TNF-alpha, IL-1beta, IL-6). Cytokine. 1999;11:839\u201348.","journal-title":"Cytokine"},{"issue":"Suppl 2","key":"343_CR30","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1111\/j.1365-2133.2007.08265.x","volume":"157","author":"MP Schon","year":"2007","unstructured":"Schon MP, Schon M. Imiquimod: mode of action. Br J Dermatol. 2007;157(Suppl 2):8\u201313.","journal-title":"Br J Dermatol"},{"key":"343_CR31","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1093\/jnci\/90.12.889","volume":"90","author":"TJ Dougherty","year":"1998","unstructured":"Dougherty TJ, Gomer CJ, Henderson BW, Jori G, Kessel D, Korbelik M, Moan J, Peng Q. Photodynamic therapy. J Natl Cancer Inst. 1998;90:889\u2013905.","journal-title":"J Natl Cancer Inst"},{"key":"343_CR32","doi-asserted-by":"publisher","first-page":"16570","DOI":"10.1038\/s41598-017-16707-5","volume":"7","author":"L Nerurkar","year":"2017","unstructured":"Nerurkar L, McColl A, Graham G, Cavanagh J. The systemic response to Topical Aldara treatment is mediated through direct TLR7 stimulation as imiquimod enters the circulation. Sci Rep. 2017;7:16570.","journal-title":"Sci Rep"},{"key":"343_CR33","doi-asserted-by":"publisher","first-page":"1772","DOI":"10.1038\/sj.bjc.6600864","volume":"88","author":"SO Gollnick","year":"2003","unstructured":"Gollnick SO, Evans SS, Baumann H, Owczarczak B, Maier P, Vaughan L, Wang WC, Unger E, Henderson BW. Role of cytokines in photodynamic therapy-induced local and systemic inflammation. Br J Cancer. 2003;88:1772\u20139.","journal-title":"Br J Cancer"},{"key":"343_CR34","doi-asserted-by":"publisher","first-page":"1498","DOI":"10.1001\/archderm.138.11.1498","volume":"138","author":"E Stockfleth","year":"2002","unstructured":"Stockfleth E, Meyer T, Benninghoff B, Salasche S, Papadopoulos L, Ulrich C, Christophers E. A randomized, double-blind, vehicle-controlled study to assess 5% imiquimod cream for the treatment of multiple actinic keratoses. Arch Dermatol. 2002;138:1498\u2013502.","journal-title":"Arch Dermatol"}],"container-title":["European Journal of Medical Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s40001-018-0343-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s40001-018-0343-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s40001-018-0343-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,2]],"date-time":"2022-09-02T22:25:34Z","timestamp":1662157534000},"score":1,"resource":{"primary":{"URL":"https:\/\/eurjmedres.biomedcentral.com\/articles\/10.1186\/s40001-018-0343-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,9,28]]},"references-count":34,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["343"],"URL":"https:\/\/doi.org\/10.1186\/s40001-018-0343-8","relation":{},"ISSN":["2047-783X"],"issn-type":[{"value":"2047-783X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,9,28]]},"assertion":[{"value":"15 July 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 September 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 September 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"45"}}